The Biologics Innovation Facility (BIF) includes an assortment of analysis tools for the quality control and characterisation of protein products, including monoclonal antibodies and recombinant proteins.
Contract Services: Analytics
Biopharmaceutical assessment
Biopharmaceuticals at BIF will be assessed for their stability, purity, quality, and quantity.
On-site capabilities
- Agilent HPLC 1260 system
- Vi-CELL BLU Cell Viability Analyzer
- LabChip GXII Touch
- Nova Biomedical Stat Profile Prime
- ForteBio BLItz System
- Perkin Elmer EnSpire Multimode Plate Reader
- Perkin Elmer LapChip GXII
- Thermo Fisher NanoDrop Microvolume Spectrophotometer
- Charles River Endosafe PTS
Additionally, at BIF you will have access to various co-facilities within Sydney for other analytical capabilities.
Enquiries
For more information about the training offered by BIF, please contact us
David Rickards, Biologics Innovation Facility Manager
Andrew Groth, Science faculty Business Development Manager
Email us